Glenmark's Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial is bioequivalent and therapeutically equivalent to the reference listed drug
Formycon AG will develop, register, manufacture and supply the product, while Zydus Lifesciences Global FZE, United Arab Emirates will be responsible for the commercialization of FYB206 in the defined territories
Biocon will acquire the residual stake held by Mylan (Viatris) for a total consideration of US$ 815 million
O'Connor brings over 30 years of leadership experience in the biotechnology and oncology sectors
The agreement allows Biocon Biologics to commercialize both its Denosumab biosimilars (Vevzuo and Evfraxy) in Europe starting December 2, 2025
This is the first and only subcutaneous immune checkpoint inhibitor available in Europe
With over two decades of extensive experience, Lal has established himself as a transformational leader in the FMCG and consumer goods sectors
Allergan Aesthetics reaffirms commitment to empowering girls through STEM mentorship and education initiatives
Glenmark’s Ropivacaine Hydrochloride Injection USP is bioequivalent and therapeutically equivalent to the reference listed drug Naropin Injection of Fresenius Kabi USA
Subscribe To Our Newsletter & Stay Updated
